ARCHIVES

Consolidation Unlikely to Save Money

This article is from The Cancer Letter archive.

Vol. 36 No. 46 | December 17, 2010

Download PDF Visit The Full Archive

Related Articles

New Drug for Lymphoma Enters Phase II Trial

May 28, 2004

NCAB Task Force Urges New Study Section For Clinical Cancer Research, Sees “Crisis”

May 7, 1993

NCI’s use of Cancer Dialogue for biospecimen network blueprint raises legal, procedural questions.

December 12, 2003

Trials Approved by NCI CTEP For The Month of February

February 24, 2012

Phase III Xilonix Study Halted Following Unscheduled Analysis

September 26, 2014

In Brief: FDA approves Three-Hour Taxol Infusion; Foti Elected President Of NCCR; Luce Retires

September 9, 1994